Table 1.
Population's socio-demographic and disease feature baseline data.
| Age (years) | 66.5 (59.7–72.2) |
| Sex (F), n (%) | 18 (33) |
| Education | |
| Bachelor's degree, n (%) | 15 (27.7) |
| High school, n (%) | 26 (48.1) |
| Upper secondary school or lower, n (%) | 13 (22) |
| Annual family income | |
| > 55.000 €, n (%) | 7 (13) |
| 28–55.000 €, n (%) | 15 (27.5) |
| <28.000 €, n (%) | 24 (44) |
| Not provided | 8 (15) |
| Comorbidities | |
| 3 or more, n (%) | 17 (31.5) |
| 1 or 2, n (%) | 21 (38.8) |
| None, n (%) | 16 (29.6) |
| Presence of caregiver | |
| Close relative (Spouse or son) | 43 (79.6) |
| Other relative or close friends | 3 (5.5) |
| None | 8 (14.8) |
| Caregiver education | |
| Bachelor's degree, n (%) | 20 (43.4) |
| High school, n (%) | 12 (66) |
| Upper secondary school or lower, n (%) | 14 (30) |
| Disease duration (years) | 6.5 (4–11) |
| Modified Hoehn & Yahr scale | 2.5 (2–3) |
| Patients on Levodopa, n (%) | 39 (80%) |
| LEDD (mgs) | 547.5 (366.25–1,061.25) |
| Patients on advanced therapies | |
| STN DBS, n (%) | 5 (9.2) |
| LCIG, n (%) | 11 (20.3) |
| UPDRS-III total score | 22 (14–32) |
| UPDRS-I total score | 1 (0–2) |
| UPDRS-II total score | 11 (7–16) |
| UPDRS-IV A & B total score | 2 (0–3) |
| NMSQ total score | 9 (5.75–13) |
| GDSsf total score | 3 (1–7) |
| PDQ8 score (%) | 18.8 (9.4–31.3) |
Data is reported as median (quartiles, QI-QIII) or frequencies (%). LEDD, Levodopa Equivalency Daily Dose; STN DBS, subthalamic nucleus deep brain stimulation; LCIG, levodopa-carbidopa intestinal gel; UPDRS, Unified Parkinson's Disease Rating Scale; NMSQ, Non-Motor Symptoms Questionnaire; GDSsf, Geriatric Depression Scale short form; PDQ8, Parkinson's Disease Questionnaire 8.